Why invest in Biotech?

This chart by Statnews explains the narrative.
In 5 years, major companies (mostly Merck with Pembrolizumab) will face massive sales losses from Gx. Few investments are better than a cash-rich Pharma firm chasing the next big thing (and you are that potential next big thing)